TLS
Triyambak Life Sciences

Nurturing Life Sciences

TLS Online

Nurturing Life Sciences

Store Blog
  • Search PYQ
  • Store
  • Blog
Login

Practice Questions

  1. Home
  2. Free Resources
  3. Practice Questions
  4. 3137
TLS Online TPP Program

#Question id: 3350


In a given population, 128 out of every 400 people has a carrier for recessive allele b that caused cancer in homozygous condition,  Assuming the population is in Hardy- Weinberg equilibrium, which of the following is the expected frequency of allele B and b in population respectively?

#Unit 9. Evolution & Diversity of Life Forms
  1. .60 and .40

  2. .80 and .20         

  3. .70 and .30

  4. .90 and .10


Answer:- Option(s): 2


To access the video solutions, Please subscribe TPP program.

Subscribe Now 
More Questions
TLS Online TPP Program

#Question id: 6982

#Unit 5. Developmental Biology

Which of the following genes control the final structures of appendages from each segment?

TLS Online TPP Program

#Question id: 6983

#Unit 5. Developmental Biology

In vertebrates, the heart forms from:

TLS Online TPP Program

#Question id: 6984

#Unit 5. Developmental Biology

Which of the following genes is unlikely to be involved in preaxial polydactyly in mice?

TLS Online TPP Program

#Question id: 6985

#Unit 5. Developmental Biology

The ventricular proliferative zone is:

TLS Online TPP Program

#Question id: 6986

#Unit 5. Developmental Biology

The use of segments as a developmental strategy in vertebrates is evident in:

TLS Online TPP Program

#Question id: 6987

#Unit 5. Developmental Biology

Which of the following statements about axon-guidance is TRUE?

TLS Triyambak Life Sciences Nurturing Life Sciences
TLS Android APP TLS IOS APP

Company

  • About us
  • Careers
  • Terms of service
  • Privacy policy
  • Our Blogs

Help & Support

  • User Guidelines
  • Refund Policy

Products

  • TLS APP
  • TPP APP

Contact Us

117/429-4 Q Block, behind Hotel DNG Grand, Sharda Nagar, Kanpur,
Uttar Pradesh 208025
India
Phone: +91 9919149001, +917007912133
Email: info@triyambak.org

© 2026 Copyright Triyambak Life Sciences Pvt Ltd. All Rights Reserved